• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS TINA-QUANT HEMOGLOBIN A1C GEN.3 - HEMOLYSATE AND WHOLE BLOOD APPLICATION; ASSAY, GLYCOSYLATED HEMOGLOBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS TINA-QUANT HEMOGLOBIN A1C GEN.3 - HEMOLYSATE AND WHOLE BLOOD APPLICATION; ASSAY, GLYCOSYLATED HEMOGLOBIN Back to Search Results
Catalog Number 05336163190
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/22/2025
Type of Reportable Event Malfunction
Event or Problem Description
There was an allegation of questionable tina-quant hemoglobin a1c gen.3 - hemolysate and whole blood application results from the cobas 6000 c501 module.Patient 1 initial result was 6.0 %.On (b)(6) 2025, the result from an afinion hba1c analyzer was 5.4 %.On (b)(6) 2025, patent 2 initial result was 5.8 %.The result from an afinion hba1c analyzer was 4.9 %.One general example was provided of an initial result of 7 % and a result from an afinion hba1c analyzer of 5.8 %.
 
Additional Manufacturer Narrative
The cobas 6000 c501 module serial number was (b)(6).The investigation is ongoing.
 
Additional Manufacturer Narrative
The field service engineer found that the sample probe was partially clogged.The probe was removed, manually cleaned, and reinstalled.The customer checked the instrument and had no further issues related to hba1c results.The investigation determined that since the sample probe was found to be partially clogged, the event is consistent with a general preanalytical issue.Correct pre-analytic sample handling is within the customer's responsibility.There is no evidence to suggest a malfunction of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TINA-QUANT HEMOGLOBIN A1C GEN.3 - HEMOLYSATE AND WHOLE BLOOD APPLICATION
Common Device Name
ASSAY, GLYCOSYLATED HEMOGLOBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key22017466
Report Number1823260-2025-01467
Device Sequence Number20992949
Product Code LCP
UDI-Device Identifier04015630926275
UDI-Public04015630926275
Combination Product (Y/N)N
Initial Reporter CountrySA
PMA/510(K) Number
K102914
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/20/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/31/2026
Device Catalogue Number05336163190
Device Lot Number805150
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 04/23/2025
Supplement Date Received by Manufacturer05/20/2025
Initial Report FDA Received Date05/14/2025
Supplement Report FDA Received Date05/20/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age27 YR
Patient SexMale
-
-